Hook / Thesis
Nu Holdings is operating with two clear structural tailwinds right now: accelerating revenue per active customer (ARPAC) and an aggressive $1 billion share buyback announced on 06/04/2026. Those two forces together make the stock compelling around current levels near $11.77. Operational momentum - including Q1 2026 revenue growth of 42% year-over-year to $5.32 billion - suggests the company can re-earn multiple expansion even as credit volatility lingers in Brazil.
My trade thesis is straightforward: buy NU now with a defined stop-loss and a mid-term target. The key bull case is that ARPAC expansion and international progress (Mexico breakeven) will continue to outpace increased provisioning and one-time cost pressure. The bear case is a sharper-than-expected credit cycle in Brazil or material margin degradation from higher funding costs. I think the former is less likely to fully offset the revenue and buyback dynamics in the next 45 trading days.
What the company does and why the market should care
Nu Holdings is a Brazil-headquartered digital banking group that has become one of Latin America’s largest fintech franchises. Management reports roughly 135 million customers across its footprint and a Brazil core that exceeds 100 million active customers with an approximately 83% monthly activity rate. The company’s product set - banking, cards, credit and payments - allows it to monetize customers multiple ways, and recent data points show revenue per customer near $15.90, which is rising as management cross-sells higher-value services.
Why this matters to investors: scale plus rising ARPAC is a high-leverage growth vector. Nu reported Q1 2026 revenue of $5.32 billion, up 42% year-over-year, and the firm is operating with improving unit economics in Mexico after achieving breakeven there. A combination of faster-than-peer ARPAC growth, operational leverage and a $1 billion buyback makes valuation upside plausible even if near-term margin pressure persists.
Hard numbers to anchor the thesis
- Market cap: approximately $56.4 billion.
- Q1 2026 revenue: $5.32 billion, +42% YoY (company reported).
- Revenue per customer / ARPAC: ~$15.90 (reported commentary).
- Free cash flow (trailing): $1.191 billion; implied FCF yield on market cap ~2.1%.
- Valuation multiples: P/E ~17.7-18.1, P/S ~3.21, P/B ~4.49, EV/EBITDA ~15.25.
- Technicals: current price $11.77, 52-week range $11.20 - $18.98, RSI ~34.7 (near oversold).
Valuation framing
On a P/E basis the stock trades in the high-teens (roughly 18x), which is reasonable for a high-growth fintech with durable customer monetization; on an EV/EBITDA basis the multiple is ~15x. Those multiples look constructive when you factor in 40%+ top-line growth and structural ARPAC upside. That said, absolute multiples are not cheap relative to legacy banks, and the market appears to be applying a haircut for credit and margin risk. The buyback ($1 billion over 12 months starting 06/04/2026) narrows the gap between intrinsic operating performance and market capitalization and should act as a tangible floor for the stock while management continues to drive ARPAC expansion.
Catalysts to drive the trade
- Buyback support - $1 billion repurchase program announced on 06/04/2026 that should reduce float and provide technical demand.
- ARPAC momentum - continued growth in revenue per customer (current data point ~$15.90) and cross-sell lifts EBITDA margins and FCF.
- Mexico expansion - Mexico breakeven removes a drag and gives optionality for further profitable international expansion.
- Operational beats - any upcoming quarter that shows continued 30%+ revenue growth and margin stabilization could re-rate the stock.
- CFO transition stabilization - the appointment of a new CFO (effective 07/13/2026) could quiet governance and finance execution concerns once visible.
Trade plan (actionable)
Entry: Long NU at $11.80.
Stop-loss: $10.25.
Target: $15.00 over the mid term (45 trading days).
Horizon rationale: I expect the trade to play out over a mid-term window because catalysts - buyback flows, a quarter of operational data confirming ARPAC improvement, and a calmer narrative on provisioning - typically take several weeks to move a name of this size. Specifically:
- Short term (10 trading days): expect choppy price action and potential volatility as headlines about credit flows continue. This is not ideal for traders seeking quick wins.
- Mid term (45 trading days): this is the primary window for this trade. The buyback is active, Q2/operational updates should start to show in-season performance, and market participants will reassess valuation vs. fundamentals.
- Long term (180 trading days): a conviction buyer could hold toward a stretch target of $18 if ARPAC, revenue growth and margins converge to show sustainable improvement and macro credit stress eases.
Position sizing & risk management: use a position size that limits loss to a predetermined percent of capital if the $10.25 stop is hit. Given event risk in Brazil and macro sensitivity, a medium risk sizing is appropriate for most retail portfolios.
Why this trade still makes sense despite credit concerns
Credit exposure in Brazil is real, but the company’s multi-product engagement and improving ARPAC give it levers to offset provisioning pressure. Management is also buying shares, which signals confidence in capital flexibility. Finally, the technical picture - RSI near 35, a 52-week low of $11.20 - implies much of the negative sentiment is priced in and the downside is increasingly limited relative to upside catalysts.
Risks and counterarguments
There are several credible reasons this trade can fail; I list the main ones below and then provide a counterargument to my own thesis.
- Brazil credit shock: a sharper deterioration in consumer credit quality or material adverse macro shock in Brazil could force larger-than-expected provisions and compress earnings materially.
- Margin compression and funding pressure: higher funding costs or worsening spreads could erode net interest margin and depress profitability despite revenue growth.
- CFO transition and execution risk: the new CFO takes effect on 07/13/2026 - any missteps in guidance, capital allocation or accounting could spook investors.
- Competition and product mix risk: intensifying competition in Latin America from local banks or other fintechs could slow ARPAC growth or require higher marketing incentives, reducing incremental margins.
- Currency volatility: BRL/USD swings can impact dollar-reported results and investor sentiment; a sharp BRL depreciation could amplify volatility around reported earnings.
Counterargument (to my bullish stance): If provisioning rises faster than revenue per customer increases - for example, if a sustained credit deterioration forces provisions equal to or greater than net revenue expansion - the stock could reprice lower despite buyback activity. In that scenario, multiples could compress to reflect an earnings reset and the buyback may not be enough to arrest share-price declines until credit normalization.
What would change my mind
I would re-evaluate the trade if any of the following occur:
- Management reports a material, sustained increase in net charge-offs or provisioning that outstrips revenue growth in consecutive quarters.
- The new CFO guidance signals structural margin deterioration or an inability to sustain share repurchases and capital return plans.
- Macro contagion in Brazil leads to a systemic tightening of credit that materially increases cost of capital for Nu’s customer base.
Conclusion
Nu is a high-conviction, defined-risk trade at current levels. The combination of accelerating ARPAC, a tangible $1 billion buyback announced on 06/04/2026, and continued international progress makes a mid-term long attractive. Valuation at ~18x earnings and EV/EBITDA ~15x is fair given growth; the downside is limited relative to upside if ARPAC and margin trends continue to improve. Enter at $11.80, place a stop at $10.25, and target $15.00 over the next 45 trading days, with a stretch target of $18 on a 180-trading-day view if the recovery gains conviction.
Key metrics (snapshot)
| Metric | Value |
|---|---|
| Market cap | $56.4B |
| Q1 2026 Revenue | $5.32B (+42% YoY) |
| Free Cash Flow (trailing) | $1.191B |
| P/E | ~18x |
| P/S | ~3.2x |
| EV/EBITDA | ~15x |
| ARPAC | ~$15.90 |
Final thought
Nu is not a risk-free pick. But the math lines up: rising revenue per customer, a pro-active buyback and a valuation that already reflects some credit anxiety create an asymmetric opportunity. Keep position sizes sensible, use the $10.25 stop to limit downside, and look for re-rating signals in the next two quarters (ARPAC continuation, margin stabilization, and steady buyback execution).